Impact of atrial fibrillation on the risk of death: the Framingham Heart Study
- PMID: 9737513
- DOI: 10.1161/01.cir.98.10.946
Impact of atrial fibrillation on the risk of death: the Framingham Heart Study
Abstract
Background: Atrial fibrillation (AF) causes substantial morbidity. It is uncertain whether AF is associated with excess mortality independent of associated cardiac conditions and risk factors.
Methods and results: We examined the mortality of subjects 55 to 94 years of age who developed AF during 40 years of follow-up of the original Framingham Heart Study cohort. Of the original 5209 subjects, 296 men and 325 women (mean ages, 74 and 76 years, respectively) developed AF and met eligibility criteria. By pooled logistic regression, after adjustment for age, hypertension, smoking, diabetes, left ventricular hypertrophy, myocardial infarction, congestive heart failure, valvular heart disease, and stroke or transient ischemic attack, AF was associated with an OR for death of 1.5 (95% CI, 1.2 to 1.8) in men and 1.9 (95% CI, 1.5 to 2.2) in women. The risk of mortality conferred by AF did not significantly vary by age. However, there was a significant AF-sex interaction: AF diminished the female advantage in survival. In secondary multivariate analyses, in subjects free of valvular heart disease and preexisting cardiovascular disease, AF remained significantly associated with excess mortality, with about a doubling of mortality in both sexes.
Conclusions: In subjects from the original cohort of the Framingham Heart Study, AF was associated with a 1.5- to 1.9-fold mortality risk after adjustment for the preexisting cardiovascular conditions with which AF was related. The decreased survival seen with AF was present in men and women and across a wide range of ages.
Comment in
-
Epidemiological and mechanistic studies of atrial fibrillation as a basis for treatment strategies.Circulation. 1998 Sep 8;98(10):943-5. doi: 10.1161/01.cir.98.10.943. Circulation. 1998. PMID: 9737512 No abstract available.
-
Atrial fibrillation and ethnicity.Circulation. 1999 Dec 21;100(25):e153. doi: 10.1161/01.cir.100.25.e153. Circulation. 1999. PMID: 10604919 No abstract available.
-
C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation.Circulation. 2001 Dec 11;104(24):2886-91. doi: 10.1161/hc4901.101760. Circulation. 2001. PMID: 11739301
Similar articles
-
Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates.Am J Cardiol. 1998 Oct 16;82(8A):2N-9N. doi: 10.1016/s0002-9149(98)00583-9. Am J Cardiol. 1998. PMID: 9809895
-
Derivation and validation of QStroke score for predicting risk of ischaemic stroke in primary care and comparison with other risk scores: a prospective open cohort study.BMJ. 2013 May 2;346:f2573. doi: 10.1136/bmj.f2573. BMJ. 2013. PMID: 23641033 Free PMC article.
-
Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study.JAMA. 1994 Mar 16;271(11):840-4. JAMA. 1994. PMID: 8114238
-
Atrial fibrillation and stroke. Mortality and causes of death after the first acute ischemic stroke.Stroke. 1997 Feb;28(2):311-5. doi: 10.1161/01.str.28.2.311. Stroke. 1997. PMID: 9040681 Review.
-
[Impact of chronic atrial fibrillation on cardiovacular mortality].Ital Heart J Suppl. 2000 Sep;1(9):1117-22. Ital Heart J Suppl. 2000. PMID: 11140280 Review. Italian.
Cited by
-
Association between first-line monotherapy with metformin and the risk of atrial fibrillation (AMRAF) in patients with type 2 diabetes.J Diabetes Complications. 2022 Nov;36(11):108315. doi: 10.1016/j.jdiacomp.2022.108315. Epub 2022 Sep 24. J Diabetes Complications. 2022. PMID: 36208567 Free PMC article.
-
Isolation and Kv channel recordings in murine atrial and ventricular cardiomyocytes.J Vis Exp. 2013 Mar 12;(73):e50145. doi: 10.3791/50145. J Vis Exp. 2013. PMID: 23524949 Free PMC article.
-
Recent clinical trials in atrial fibrillation in hypertensive patients.Curr Hypertens Rep. 2012 Aug;14(4):350-9. doi: 10.1007/s11906-012-0268-5. Curr Hypertens Rep. 2012. PMID: 22576674 Review.
-
Clinical strategies for selecting oral anticoagulants in patients with atrial fibrillation.J Thromb Thrombolysis. 2013 Aug;36(2):163-74. doi: 10.1007/s11239-013-0956-2. J Thromb Thrombolysis. 2013. PMID: 23846737 Free PMC article. Review.
-
Nicotinamide Phosphoribosyltransferase (Nampt)/Nicotinamide Adenine Dinucleotide (NAD) Axis Suppresses Atrial Fibrillation by Modulating the Calcium Handling Pathway.Int J Mol Sci. 2020 Jun 30;21(13):4655. doi: 10.3390/ijms21134655. Int J Mol Sci. 2020. PMID: 32629939 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous